Yunda Huang

Fred Hutchinson Cancer Research Center

United States

Research Interests

Explore related searches

Professors in United States Professors in Immunology Immunology professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (14)

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2020

Collaborators (10)

Bo Zhang

Assistant Professor of Biostatistics

UNITED STATES

View details

Peter Gilbert

Fred Hutchinson Cancer Research Center

UNITED STATES

View details

Maria Lemos

Fred Hutchinson Cancer Research Center

UNITED STATES

View details

David Benkeser

Assistant Professor

Emory University

UNITED STATES

View details

Stephen Walsh

Assistant Professor

Brigham and Women's Hospital

UNITED STATES

View details

Michal Juraska

Fred Hutchinson Cancer Research Center

UNITED STATES

View details

Allan deCamp

Fred Hutchinson Cancer Research Center

UNITED STATES

View details

Raphael Gottardo

University of Lausanne

SWITZERLAND

View details

Bryan Mayer

Fred Hutchinson Cancer Research Center

UNITED STATES

View details

Joshua Schiffer

Fred Hutchinson Cancer Research Center

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Yunda Huang

Research Interests

Explore related searches

Contact this professor

Articles (14)

Dose finding in early-phase human immunodeficiency virus type 1 prevention monoclonal antibody clinical trials

Fixed dosing versus weight-based dosing of HIV-1 prophylactic monoclonal antibodies in adults: a post-hoc, cross-protocol pharmacokinetics modelling study

Pharmacokinetics Analysis of Serum and Rectal Tissue Concentrations of a Pair of Anti‐HIV Monoclonal Antibodies, VRC01 and VRC01LS, in Adults without HIV

Author Correction: High monoclonal neutralization titers reduced breakthrough HIV-1 viral loads in the Antibody Mediated Prevention trials

Enhanced and sustained biodistribution of HIV-1 neutralizing antibody VRC01LS in human genital and rectal mucosa

Publisher Correction: Immune correlates analysis of the PREVENT-19 COVID-19 vaccine efficacy clinical trial

Immune correlates analysis of the PREVENT-19 COVID-19 vaccine efficacy clinical trial

High monoclonal neutralization titers reduced breakthrough HIV-1 viral loads in the Antibody Mediated Prevention trials

Adults on pre-exposure prophylaxis (tenofovir-emtricitabine) have faster clearance of anti-HIV monoclonal antibody VRC01

Optimizing clinical dosing of combination broadly neutralizing antibodies for HIV prevention

Neutralization titer biomarker for antibody-mediated prevention of HIV-1 acquisition

Prediction of serum HIV-1 neutralization titers of VRC01 in HIV-uninfected Antibody Mediated Prevention (AMP) trial participants

Rectal tissue and vaginal tissue from intravenous VRC01 recipients show protection against ex vivo HIV-1 challenge

Robust antibody and cellular responses induced by DNA-only vaccination for HIV

Collaborators (10)

Bo Zhang

Peter Gilbert

Maria Lemos

David Benkeser

Stephen Walsh

Michal Juraska

Allan deCamp

Raphael Gottardo

Bryan Mayer

Joshua Schiffer

Make your next move.